RPG Life Sciences board approves new CFO, sets up API subsidiary, approves API biz transfer
RPGLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.3 pts more than Nifty Microcap 250 and 2.9 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Board approved: (1) Mr. Amol Lone appointed as new CFO from Dec 15, 2025. (2) Incorporation of wholly owned subsidiary RPG Active Pharma Limited for the API business. (3) Transfer of API business to the WOS as going concern for approximately Rs 50 crore. (4) Investment of up to Rs 105 crore in the WOS. The API segment contributed about 13.8% of FY25 revenue (Rs 90.24 crore). Transfer expected by March 31, 2026.
API business hived into new WOS with Rs 105 crore investment commitment. New CFO also appointed. Transfer expected by March 31, 2026.